Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: An exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 235-241

  Pederson, Aaron W ^a   Fricano, Janine ^a   Correa, David ^a   Pelizzari, Charles A ^a   Liauw, Stanley L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

DVH guidelines; IMRT; Late toxicity; Prostate cancer

Indexed keywords

AFTER-TREATMENT; ANDROGEN DEPRIVATION THERAPY; BLADDER TISSUE; DOSE-VOLUME; DOSE-VOLUME HISTOGRAMS; DVH GUIDELINES; GASTROINTESTINAL TOXICITIES; IMRT; INTENSITY-MODULATED RADIATION THERAPY; LOCALIZED PROSTATE CANCER; LOW RATES; MULTI VARIATE ANALYSIS; PROSTATE CANCERS; RECTAL DOSE CONSTRAINTS; SEMINAL VESICLE;

DISEASES; GRAPHIC METHODS; MULTIVARIANT ANALYSIS; PATIENT MONITORING; RADIOTHERAPY; TISSUE; TOXICITY;

PHYSICAL THERAPY;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BLADDER; CANCER LOCALIZATION; CHRONIC TOXICITY; CYSTITIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE FREE INTERVAL; DISEASE SEVERITY; DOSE VOLUME HISTOGRAM; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PELVIS; PRIORITY JOURNAL; PROCTITIS; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIATION INJURY; RECTUM; RISK ASSESSMENT; SEMINAL VESICLE; URINARY FREQUENCY; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; ORGANS AT RISK; PROCTITIS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TUMOR BURDEN; URINARY BLADDER; UROGENITAL SYSTEM;

EID: 83955165980     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.058     Document Type: Article

References (38)

1. D.P. Dearnaley, M.R. Sydes, and J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487
2. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
3. A. Pollack, A.L. Hanlon, and E.M. Horwitz Prostate cancer radiotherapy dose response: An update of the Fox Chase experience J Urol 171 2004 1132 1136
4. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239
5. L.J. Boersma, M. van den Brink, and A.M. Bruce Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms Int J Radiat Oncol Biol Phys 41 1998 83 92
6. D.B. Chism, E.M. Horwitz, and A.L. Hanlon Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement Int J Radiat Oncol Biol Phys 55 2003 71 77
7. C. Cozzarini, C. Fiorino, and G.L. Ceresoli Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy) Int J Radiat Oncol Biol Phys 55 2003 688 694
8. E.H. Huang, A. Pollack, and L. Levy Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 54 2002 1314 1321
9. L.W. Chan, P. Xia, and A.R. Gottschalk Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 69 77
10. J.M. Michalski, H. Gay, and A. Jackson Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
11. C. Fiorino, R. Valdagni, and T. Rancati Dose-volume effects for normal tissues in external radiotherapy: Pelvis Radiother Oncol 93 2009 153 167
12. S.L. Gulliford, K. Foo, and R.C. Morgan Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: Evidence from MRC RT01 Trial ISRCTN 47772397 Int J Radiat Oncol Biol Phys 76 2010 747 754
13. A. Harsolia, C. Vargas, and D. Yan Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study Int J Radiat Oncol Biol Phys 69 2007 1100 1109
14. C. Fiorino, G. Fellin, and T. Rancati Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: Preliminary results of a multicenter prospective study Int J Radiat Oncol Biol Phys 70 2008 1130 1137
15. M.R. Cheung, S.L. Tucker, and L. Dong Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 67 2007 1059 1065
16. M.J. Chen, E. Weltman, and R.M. Hanriot Intensity modulated radiotherapy for localized prostate cancer: Rigid compliance to dose-volume constraints as a warranty of acceptable toxicity? Radiat Oncol 2 2007 6
17. S.T. Peeters, J.V. Lebesque, and W.D. Heemsbergen Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 64 2006 1151 1161
18. L. Fokdal, H. Honore, and M. Hoyer Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy Radiother Oncol 74 2005 203 210
19. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
20. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
21. J. Vaarkamp, R. Malde, and S. Dixit A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer J Med Imaging Radiat Oncol 53 2009 310 317
22. C.C. Goulet, M.G. Herman, and D.W. Hillman Estimated limits of IMRT dose escalation using varied planning target volume margins Phys Med Biol 53 2008 3777 3788
23. J. Mohler, R.R. Bahnson, and B. Boston NCCN clinical practice guidelines in oncology: Prostate cancer J Natl Compr Canc Netw 8 2010 162 200
24. S.L. Liauw, R.R. Weichselbaum, and C. Rash Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer Technol Cancer Res Treat 8 2009 201 206
25. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
26. A.B. Jani, A. Su, and D. Correa Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields Prostate Cancer Prostatic Dis 10 2007 82 86
27. O. Cahlon, M.J. Zelefsky, and A. Shippy Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes Int J Radiat Oncol Biol Phys 71 2008 330 337
28. G.O. De Meerleer, V.H. Fonteyne, and L. Vakaet Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control Radiother Oncol 82 2007 160 166
29. S.A. Vora, W.W. Wong, and S.E. Schild Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 68 2007 1053 1058
30. M.J. Zelefsky, H. Chan, and M. Hunt Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 176 2006 1415 1419
31. J.M. Michalski, K. Bae, and M. Roach Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 2010 14 22
32. C.W. Stevens, P.F. Wong, and D. Rice Treatment planning system evaluation for mesothelioma IMRT Lung Cancer 49 Suppl. 1 2005 S75 S81
33. K.M. Ayyangar, A.Y. Fung, and S. Li Dose volume histogram comparison between ADAC Pinnacle and Nomos Corvus systems for IMRT Australas Phys Eng Sci Med 28 2005 1 7
34. H.T. Chung, B. Lee, and E. Park Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer Int J Radiat Oncol Biol Phys 71 2008 1167 1174
35. K.S. Choe, A.B. Jani, and S.L. Liauw External beam radiotherapy for prostate cancer patients on anticoagulation therapy: How significant is the bleeding toxicity? Int J Radiat Oncol Biol Phys 76 2010 755 760
36. A. Trotti, R. Byhardt, and J. Stetz Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
37. V. Moiseenko, M. Liu, and S. Kristensen Effect of bladder filling on doses to prostate and organs at risk: A treatment planning study J Appl Clin Med Phys 8 2007 55 68
38. K. Devisetty, K.C. Zorn, and M.H. Katz External beam radiation therapy after transurethral resection of the prostate: A report on acute and late genitourinary toxicity Int J Radiat Oncol Biol Phys 77 2010 1060 1065